The following information is based on a press release from Medivir AB (Medivir) dated January 30, 2015 and may be subject to change.
Medivir´s Extraordinary General Meeting (EGM) held on November 20, 2014 approved a decrease in share capital in form of a voluntary redemption with cash repayment to the shareholders. The board has decided on the final conditions. Every seven (7) shares held entitle the shareholders to redeem one (1) share for a cash payment of SEK 140.00. The scheduled Ex-date is February 4, 2015.
NASDAQ OMX Derivatives Markets will carry out a re-calculation of options, forwards and futures in Medivir (MVIR).
For further information, please see the attached file.
